| scholarly article | Q13442814 |
| P356 | DOI | 10.1039/C5CC10367C |
| P698 | PubMed publication ID | 27027105 |
| P2093 | author name string | Lingling Li | |
| Haiyang Xie | |||
| Lin Zhou | |||
| Shusen Zheng | |||
| Xiao Xu | |||
| Jianguo Wang | |||
| Hangxiang Wang | |||
| Tao Fang | |||
| Jianmei Chen | |||
| P2860 | cites work | Biotin-guided anticancer drug delivery with acidity-triggered drug release | Q38877017 |
| The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy. | Q39274501 | ||
| EphA2 Up-regulation induced by deoxycholic acid in human colon carcinoma cells, an involvement of extracellular signal-regulated kinase and p53-independence | Q40625283 | ||
| Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma | Q41074002 | ||
| Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug | Q43804754 | ||
| An activatable theranostic for targeted cancer therapy and imaging. | Q51747526 | ||
| Timeline: Chemotherapy and the war on cancer. | Q53313789 | ||
| A Small-Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors | Q57911941 | ||
| A bivalent small molecule-drug conjugate directed against carbonic anhydrase IX can elicit complete tumour regression in mice | Q57911942 | ||
| Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling | Q57983629 | ||
| Bis-sulfide bioconjugates for glutathione triggered tumor responsive drug release | Q58202911 | ||
| A perspective on cancer cell metastasis | Q28307891 | ||
| Tumour-cell invasion and migration: diversity and escape mechanisms | Q29547894 | ||
| Antibody conjugate therapeutics: challenges and potential | Q34224801 | ||
| Small targeted cytotoxics: current state and promises from DNA-encoded chemical libraries | Q34538606 | ||
| Tumor-penetrating iRGD peptide inhibits metastasis | Q34978216 | ||
| Tissue-penetrating delivery of compounds and nanoparticles into tumors | Q35016106 | ||
| Structure-based rational design of prodrugs to enable their combination with polymeric nanoparticle delivery platforms for enhanced antitumor efficacy. | Q35241553 | ||
| Non-invasive, real-time reporting drug release in vitro and in vivo | Q35800904 | ||
| Neuropilins in tumor biology | Q37400423 | ||
| Unravelling the complexity of metastasis - molecular understanding and targeted therapies | Q37937424 | ||
| Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. | Q38127545 | ||
| Antibody-drug conjugates: an emerging concept in cancer therapy | Q38200071 | ||
| Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. | Q38311815 | ||
| Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy | Q38785651 | ||
| P433 | issue | 32 | |
| P921 | main subject | cell growth | Q189159 |
| P304 | page(s) | 5601-5604 | |
| P577 | publication date | 2016-03-30 | |
| P1433 | published in | Chemical Communications | Q426303 |
| P1476 | title | Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo | |
| P478 | volume | 52 |
| Q57377325 | A facile supramolecular approach to fabricate multifunctional upconversion nanoparticles as a versatile platform for drug loading, in vivo delivery and tumor imaging |
| Q40333912 | Albumin nanoparticle encapsulation of potent cytotoxic therapeutics shows sustained drug release and alleviates cancer drug toxicity |
| Q43095122 | Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations. |
| Q47427416 | Self-assembly of peptide amphiphiles for drug delivery: the role of peptide primary and secondary structures. |
| Q64890853 | The regio-selective synthesis of 10-hydroxy camptothecin norcantharidin conjugates and their biological activity evaluation in vitro. |
Search more.